266 related articles for article (PubMed ID: 18344002)
1. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.
Brady JE; Friedman SR; Cooper HL; Flom PL; Tempalski B; Gostnell K
J Urban Health; 2008 May; 85(3):323-51. PubMed ID: 18344002
[TBL] [Abstract][Full Text] [Related]
2. Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.
Cooper HL; Brady JE; Friedman SR; Tempalski B; Gostnell K; Flom PL
J Urban Health; 2008 Nov; 85(6):826-56. PubMed ID: 18709555
[TBL] [Abstract][Full Text] [Related]
3. Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas.
Pouget ER; Friedman SR; Cleland CM; Tempalski B; Cooper HL
J Urban Health; 2012 Jun; 89(3):527-64. PubMed ID: 22411420
[TBL] [Abstract][Full Text] [Related]
4. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.
Tempalski B; Lieb S; Cleland CM; Cooper H; Brady JE; Friedman SR
J Urban Health; 2009 Jan; 86(1):132-54. PubMed ID: 19015995
[TBL] [Abstract][Full Text] [Related]
5. Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas.
Chatterjee S; Tempalski B; Pouget ER; Cooper HL; Cleland CM; Friedman SR
AIDS Behav; 2011 Oct; 15(7):1570-8. PubMed ID: 21739288
[TBL] [Abstract][Full Text] [Related]
6. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992-2013.
Williams LD; Ibragimov U; Tempalski B; Stall R; Satcher Johnson A; Wang G; Cooper HLF; Friedman SR
Ann Epidemiol; 2020 May; 45():12-23. PubMed ID: 32439148
[TBL] [Abstract][Full Text] [Related]
7. HIV among injection drug users in large US metropolitan areas, 1998.
Friedman SR; Lieb S; Tempalski B; Cooper H; Keem M; Friedman R; Flom PL
J Urban Health; 2005 Sep; 82(3):434-45. PubMed ID: 16014877
[TBL] [Abstract][Full Text] [Related]
8. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.
Tempalski B; Pouget ER; Cleland CM; Brady JE; Cooper HL; Hall HI; Lansky A; West BS; Friedman SR
PLoS One; 2013; 8(6):e64789. PubMed ID: 23755143
[TBL] [Abstract][Full Text] [Related]
9. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users.
Friedman SR; Tempalski B; Cooper H; Perlis T; Keem M; Friedman R; Flom PL
J Urban Health; 2004 Sep; 81(3):377-400. PubMed ID: 15273263
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
11. Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992-2002.
Roberts ET; Friedman SR; Brady JE; Pouget ER; Tempalski B; Galea S
Drug Alcohol Depend; 2010 Jan; 106(2-3):142-53. PubMed ID: 19748745
[TBL] [Abstract][Full Text] [Related]
12. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
13. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.
Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I
Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037
[TBL] [Abstract][Full Text] [Related]
14. Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas.
Tempalski B; Cleland CM; Pouget ER; Chatterjee S; Friedman SR
Subst Abuse Treat Prev Policy; 2010 Sep; 5():23. PubMed ID: 20858258
[TBL] [Abstract][Full Text] [Related]
15. An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.
Lieb S; Friedman SR; Zeni MB; Chitwood DD; Liberti TM; Gates GJ; Metsch LR; Maddox LM; Kuper T
J Urban Health; 2004 Sep; 81(3):401-15. PubMed ID: 15273264
[TBL] [Abstract][Full Text] [Related]
16. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001.
Muga R; Sanvisens A; Bolao F; Tor J; Santesmases J; Pujol R; Tural C; Langohr K; Rey-Joly C; Muñoz A
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S29-33. PubMed ID: 16769442
[TBL] [Abstract][Full Text] [Related]
17. Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS.
Friedman SR; West BS; Pouget ER; Hall HI; Cantrell J; Tempalski B; Chatterjee S; Hu X; Cooper HL; Galea S; Des Jarlais DC
PLoS One; 2013; 8(2):e57201. PubMed ID: 23437341
[TBL] [Abstract][Full Text] [Related]
18. Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia.
Hickman M; Hope V; Platt L; Higgins V; Bellis M; Rhodes T; Taylor C; Tilling K
Drug Alcohol Rev; 2006 Mar; 25(2):131-40. PubMed ID: 16627302
[TBL] [Abstract][Full Text] [Related]
19. Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia.
Walkup J; Akincigil A; Hoover DR; Siegel MJ; Amin S; Crystal S
Public Health Rep; 2011; 126 Suppl 3(Suppl 3):89-101. PubMed ID: 21836742
[TBL] [Abstract][Full Text] [Related]
20. Trends in Adolescent Heroin and Injection Drug Use in Nine Urban Centers in the U.S., 1999-2017.
Brighthaupt SC; Schneider KE; Johnson JK; Jones AA; Johnson RM
J Adolesc Health; 2019 Aug; 65(2):210-215. PubMed ID: 31331542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
